Ognomy Sleep

Ognomy Sleep operates a virtual sleep apnea care network that shifts the diagnosis and treatment of obstructive sleep apnea (OSA) from clinical sleep centers into patients' homes. Founded by sleep medicine physician Dr. Daniel Rifkin, the Buffalo, New York-based company connects patients with board-certified sleep medicine specialists through video consultations, coordinates at-home sleep testing kits, and manages ongoing therapy support, including CPAP devices, oral appliances, Inspire implant referrals, and, where clinically appropriate, GLP-1 medications such as Zepbound. The platform integrates with consumer wearables like the Oura Ring to incorporate biometric sleep data into clinical decision-making, and partners with device makers such as ResMed and Inspire Medical Systems. Ognomy Sleep serves both individual patients and referring healthcare providers, offering the latter a no-cost referral pathway. The company operates in all 50 US states and is in-network with insurance covering more than 200 million Americans, addressing a large and largely underdiagnosed patient population, with estimates suggesting over 80% of people with sleep apnea remain undiagnosed or untreated. It has reported serving more than 11,000 patients to date. Keywords: sleep apnea, telemedicine, virtual healthcare, home sleep testing, CPAP, Inspire therapy, digital health, sleep medicine, patient care coordination.